Explore
Validate
LearnABIN1981896
antibody from antibodies-online
Targeting: CTLA4
CD, CD152, CELIAC3, CTLA-4, GSE, IDDM12
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1981896 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) antibody (PE)
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Yellow dye
- Isotype
- IgG
- Antibody clone number
- BNI3
- Vial size
- 100 tests
- Storage
- Store in the dark at 2-8°C. Do not freeze. Avoid prolonged exposure to light. Do not use after expiration date stamped on vial label.
- Handling
- Do not freeze. Avoid prolonged exposure to light.Do not use after expiration date stamped on vial label. Short-term exposure to room temperature should not affect the quality of the reagent. However, if reagent is stored under any conditions other than those specified, the conditions must be verified by the user.
Submitted references [The use of multi-color flow cytometry for identification of functional markers of nTregs in patients with severe asthma].
Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.
Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.
Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
Kraszula L, Eusebio M, Kupczyk M, Kuna P, Pietruczuk M
Pneumonologia i alergologia polska 2012;80(5):389-401
Pneumonologia i alergologia polska 2012;80(5):389-401
Site-directed in vitro immunization leads to a complete human monoclonal IgG4 lambda that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands.
Chin LT, Chu C, Chen HM, Hsu SC, Weng BC, Chu CH
BMC biotechnology 2007 Aug 23;7:51
BMC biotechnology 2007 Aug 23;7:51
Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.
Steiner K, Moosig F, Csernok E, Selleng K, Gross WL, Fleischer B, Bröker BM
Clinical and experimental immunology 2001 Oct;126(1):143-50
Clinical and experimental immunology 2001 Oct;126(1):143-50
Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
Steiner K, Waase I, Rau T, Dietrich M, Fleischer B, Bröker BM
Clinical and experimental immunology 1999 Mar;115(3):451-7
Clinical and experimental immunology 1999 Mar;115(3):451-7
No comments: Submit comment
No validations: Submit validation data